InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Kolaja Carey OConnor. Director active across 1 company, notably Revance Therapeutics, Inc.. Aggregated, 6 disclosures have been logged. Activity tracked since 5 May 2021. The latest transaction was filed on 4 February 2025 (U). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Kolaja Carey OConnor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
16,561 shares@ US$3.6558.6% of flowCommon StockSEC:0000950170-25-015353:0
15,000 shares0Common StockSEC:0001479290-24-000087:0
2,500 shares@ US$18.1241.4% of flowCommon StockSEC:0001479290-23-000080:0
3,534 shares0Common StockSEC:0001479290-23-000061:0
6,059 shares0Common StockSEC:0001479290-22-000062:0
674 shares0Common StockSEC:0001479290-21-000110:0
6 of 6 declarations
About Kolaja Carey OConnor
Kolaja Carey OConnor is a declarant linked to Revance Therapeutics, Inc., where he is a Director. The record shows 7 filings in total, and the most recent filings available cover the period from 2021-05-07 to 2025-02-06, with the modal transaction nature shown as Attribution.
